Sort publications on year

  • Prise en charge de l’insuffisance cardiaque sévère dans l’étude EPICAL en Lorraine

    FAGNANI F, BUTEAU L, VIRION JM, BRIANCON S, ZANNAD F

    Thérapie ; 2001;56(1):5-10

  • Pharmaco - Epidemiology

    Pregnancy-induced changes in lower extremity superficial veins: an ultrasound scan study

    BOIVIN P, CORNU-THENARD A, CHARPAK Y

    J Vasc Surg ; 2000;32:570-574

  • Pharmaco - Epidemiology

    Epidémiologie de l’insuffisance cardiaque en France : approche médico-économique

    FAGNANI F

    La Lettre du Cardiologue 1er Trimestre 2000 ; IV-VI

  • Pharmaco-Economics

    Economic evaluation of enoxaparin versus heparin in unstable angina: a French sub-study of the ESSENCE trial

    DETOURNAY B, HUET X, FAGNANI F, MONTALESCOT G

    PharmacoEconomics ; 2020;18(1):83-89

  • Biometry and database analysis

    Outcomes and management costs of peripheral artery disease in France

    BURA RIVIERE A, BOUEE S, LAURENDEAU C, TORRETON E, GOURMELEN J, THOMAS-DELECOURT F.

    J Vasc Surg ; 2018;67(6):1834-1843

  • Others

    DEPIVIH 2: Use of three HIV testing methods in French primary care settings – ELISA laboratory screening versus two rapid point-of-care HIV tests.

    PAPADIMA D, GAUTHIER R, PREVOTEAU DU CLARY F, BOUEE S, CONORT G, LIVROZET JM, TAULERA O, WAJSBROT A, MAJERHOLC C, PETER JM, AUBERT JP

    Med Mal Infect ; 2018;48(2018):122-129

  • Pharmaco-Economics

    Conséquences économiques du suivi biologique et des complications médicales en lien avec l’utilisation des anticoagulants injectables en France.

    PAUBEL P, COUSIN M, AMAR C, GOURMELEN  J, FABRON C, DETOURNAY B

    J Mal Vasc ; 2016;41:371-377

  • Biometry and database analysis

    Outcomes following acute hospitalised myocardial infarction in France: An insurance claims database analysis

    BLIN P, PHILIPPE F, BOUEE S, LAURENDEAU C, TORRETON E, GOURMELIN J, LEPROUST S , LEVY-BACHELOT L, STEG PG

    Int J Cardiol - 2016 ; 219 : 387-393

  • Pharmaco - Epidemiology

    Incidence of venous thromboembolism in France: a retrospective analysis of a national insurance claims database.

    BOUEE S, EMERY C, SAMSON A, GOURMELEN J, BAILLY C, COTTE FE.

    Thromb J. ; 2016;14(4)

  • Pharmaco - Epidemiology

    Incidence of Cardiovascular Events Following Myocardial Infarction in France: an Observational Analysis Using a Claims Database.

    PHILIPPE F, BLIN P, LAURENDEAU C, BOUEE S, GOURMELEN J, LEVY BACHELOT L, LEPROUST S, STEG PG.

    Value Health ; 2015;18(7):A382

  • Pharmaco-Economics

    Increased Costs Due To Myocardial Infarction (Mi) In France: An Observational Analysis Using A Claims Database.

    BLIN P, PHILIPPE F, LAURENDEAU C, BOUEE S, GOURMELEN J, LEVY BACHELOT L, LEPROUST S, STEG PG.

    Value Health ; 2015;18(7):A386

  • Pharmaco - Epidemiology

    Characteristics and management of outpatients with history of or current atrial fibrillation : the observational French EPHA study

    COHEN A, DALLONGEVILLE J, DURAND-ZALESKI I, BOUÉE S, LE HEUZEY JY, the EPHA Investigators

    Arch Cardiovasc Dis ; 2010;103(6-7):376-387

  • Pharmaco - Epidemiology

    Epidemiology of atrial fibrillation in France : extrapolation of international epidemiological data to France and analysis of french hospitalization data

    CHARLEMAGNE A, BLACHER J, COHEN A, COLLET JP, DIEVART F, DE GROOTE P, HANON O, LEENARDT A, PINEL JF, PISICA-DONOSE G, LE HEUZEY JY

    Arch Cardiovasc Dis ; 2011;104:115-124

  • Pharmaco-Economics

    Long term treatment of atrial fibrillation in elderly patients: A decision analysis

    LAFUENTE C, EMERY C, LAURENDEAU C, FAGNANI F, BERGMANN JF

    Int J Cardiol ; 2012;155(1):102-109